WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2024-03-152,704$8.64
$23.36kBuy
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2024-02-221,254$8.71
$10.92kSell
Richard A. GrahamSVP RESEARCH DEVELOPMENT2024-02-2019,294$8.92
$172.10kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2024-02-2037,196$8.92
$331.79kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2024-02-2018,219$8.92
$162.51kSell
Aziz SawafSVP CHIEF FINANCIAL OFFICER2024-02-2017,036$8.92
$151.96kSell
Aine MillerSVP DEV HEAD OF IRE OFFICE2024-02-2011,782$8.92
$105.10kSell
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2024-02-2017,595$8.92
$156.95kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2023-11-211,378$10.29
$14.18kSell
Richard A. GrahamSVP RESEARCH DEVELOPMENT2023-11-2012,630$10.37
$130.97kSell

1 of 4

TBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Glaxosmithkline PLC20.02%9,644,807$91.24MInsider
Weiss Asset Management LP15.48%7,457,060$70.54MInsider
Weiss Asset Management LP15.48%7,457,060$70.54MInstitution
Baupost Group LLC15.40%7,419,226$70.19MInstitution
Madison Avenue Partners LP14.56%7,012,226$66.34MInstitution
Eli Samaha14.56%7,012,226$66.34MInsider
Blackrock Inc9.53%4,587,834$43.40MInstitution
Vanguard Group Inc7.24%3,489,262$33.01MInstitution
Irenic Capital Management LP5.73%2,760,948$26.12MInstitution
Pictet Asset Management Holding Sa4.50%2,168,397$20.51MInstitution

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH60.28%39.72%Net SellingNet Selling
EDIT64.04%35.96%Net SellingNet Selling
OCS10.87%0.00%
THRD73.29%26.71%Net BuyingNet Buying
STTK56.96%26.49%Net SellingNet Selling
View Top Biotech Stocks

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 101.35% institutional shareholders, 66.79% Theravance Biopharma insiders, and 0.00% retail investors. Glaxosmithkline PLC is the largest individual Theravance Biopharma shareholder, owning 9.64M shares representing 20.02% of the company. Glaxosmithkline PLC's Theravance Biopharma shares are currently valued at $88.93M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.